- Home
- Browse
- Defense Health Agency Contracting Activity - DHACA
- HT942526DMDRPIDA
DoW Duchenne Muscular Dystrophy, Idea Development Award
- Deadline
- 2026-09-18
- 15 days left
- Award ceiling
- —
- Awards
- 5
- Posted
- 2026-06-17
Summary
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. […]
The rest of this announcement — free with an account
- →The full announcement text, not the first two sentences
- →The review-criteria section of this announcement, extracted in full
- →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- →What similar funded projects received, from 219,000 past awards
No card required. Browsing and your first match are free.
More from Defense Health Agency Contracting Activity - DHACA
See all →DoW Vision, Mentored Clinical Research Award
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training.
Review criteria on fileDoW Hearing Restoration Focused Research Award
Summary: The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury.
Review criteria on fileDoW Neurofibromatosis Research Academy – Leadership Award
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as…
Review criteria on fileDoW Reconstructive Transplant, Concept Award
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Concept Award supports the exploration of highly innovative new concepts or untested theories that address an important problem relevant to reconstructive transplantation. The Concept Award does not support clinical trials .
Review criteria on fileAlso in musculoskeletal
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileSBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileOfficial announcement: https://www.grants.gov/search-results-detail/362848Source: grants_gov. Always confirm dates with the funder.